$1.57
0[0.00%]
At close: Apr 17
$1.57
0[0.00%]
After Hours: 4:12PM EDT
NextCure
(NASDAQ:NXTC)Latest News for NextCure Stock (NASDAQ:NXTC)
NextCure Stock (NASDAQ: NXTC)
Categories: All
Friday, March 22, 2024
Thursday, March 21, 2024
- Needham Maintains Buy on NextCure, Maintains $4 Price TargetBenzinga Newsdesk - Mar 21, 2024, 2:59PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Mar 21, 2024, 1:31PM
- NextCure shares are trading higher after the company reported a year-over-year increase in FY23 EPS results.Benzinga Newsdesk - Mar 21, 2024, 12:21PM
- NextCure Expects Its Existing Cash, Cash Equivalents And Marketable Securities Will Enable It To Fund Operating Expenses And Capital Expenditures Into The Second Half Of 2026Benzinga Newsdesk - Mar 21, 2024, 8:57AM
- NextCure Reports FY23 EPS $(2.25) Vs $(2.69) YoY; Cash, Cash Equivalents, And Marketable Securities As Of December 31, 2023, Were $108.3MBenzinga Newsdesk - Mar 21, 2024, 8:56AM
Wednesday, March 06, 2024
Tuesday, March 05, 2024
Friday, February 16, 2024
Thursday, January 18, 2024
Thursday, December 21, 2023
Thursday, December 14, 2023
- Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Dec 14, 2023, 12:56PM
- NextCure shares are trading lower after the company provided year-end clinical pipeline updates.Benzinga Newsdesk - Dec 14, 2023, 12:49PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Dec 14, 2023, 12:32PM
- Needham Maintains Buy on NextCure, Lowers Price Target to $4Benzinga Newsdesk - Dec 14, 2023, 11:30AM
- US Stocks Higher; Initial Jobless Claims Fall To 202,000Avi Kapoor - Dec 14, 2023, 9:40AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Dec 14, 2023, 8:07AM
- NextCure Issues Year-End Clinical Pipeline Updates, Says Phase 1b Combination Trial of NC410 With Pembrolizumab Is Ongoing, Company Is Actively Seeking Strategic Partners To Accelerate Global Development Of ProgramsBenzinga Newsdesk - Dec 14, 2023, 6:48AM
Wednesday, November 15, 2023
Thursday, November 02, 2023
Tuesday, October 17, 2023
Tuesday, September 26, 2023
Thursday, September 07, 2023
Tuesday, September 05, 2023
Tuesday, August 08, 2023
Friday, August 04, 2023
Thursday, August 03, 2023
Wednesday, June 21, 2023
Tuesday, June 13, 2023
Friday, May 05, 2023
Thursday, May 04, 2023
Tuesday, April 04, 2023
Friday, March 03, 2023
Monday, December 19, 2022
Tuesday, November 29, 2022
Monday, November 28, 2022
Thursday, November 17, 2022
Wednesday, November 16, 2022
Tuesday, November 15, 2022
Thursday, November 10, 2022
Monday, November 07, 2022
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Nov 7, 2022, 1:28PM
- NextCure Presents Initial Data From Clinical Trial Of NC762 And A Trial In Progress Poster For NC410 Combo At The 2022 Society For Immunotherapy Of Cancer Annual MeetingBenzinga Newsdesk - Nov 7, 2022, 8:12AM
- Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From FridayLisa Levin - Nov 7, 2022, 3:07AM
Friday, November 04, 2022
- Ladenburg Thalmann Downgrades NextCure to NeutralBenzinga Newsdesk - Nov 4, 2022, 2:52PM
- Stocks That Hit 52-Week Lows On FridayBenzinga Insights - Nov 4, 2022, 12:57PM
- Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day SessionLisa Levin - Nov 4, 2022, 12:54PM
- NextCure shares are trading lower after the company reported Q3 EPS results were lower year over year.Michael Horton - Nov 4, 2022, 10:47AM